Cargando…
TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer
Pancreatic cancer (PC) is an aggressive malignancy with few treatment options, and improved treatment strategies are urgently required. TYRO3, a member of the TAM receptor tyrosine kinase family, is a known oncogene; however, the relationship between TYRO3 expression and PC chemoresistance remains t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803781/ https://www.ncbi.nlm.nih.gov/pubmed/36577166 http://dx.doi.org/10.1016/j.tranon.2022.101608 |